Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

N/ANot Yet RecruitingNCT06049485

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in medical studies is highly skewed towards particular demographic groups of people. This research will invite several participants to gather a wide range of information on clinical trial experiences for follicular lymphoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of follicular lymphoma. The data collected from this study will help improve future outcomes for all follicular lymphoma patients as well as those in under-represented demographic groups.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Follicular Lymphoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Participant must be 18 years of age or older * Patient has been diagnosed with follicular lymphoma * Patient has access to a home internet connection in order to provide regular updates through the course of the study Exclusion Criteria: * Women of childbearing potential without a negative pregnancy test; or women who are lactating. * Inability to provide written informed consent * Patients receiving any other investigational agents

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Number of patients who decide to enroll in a follicular lymphoma clinical research

Time frame: 3 months

Rate of patients who remain in a follicular lymphoma medical study to trial completion

Time frame: 12 months